跳至主要内容
临床试验/JPRN-UMIN000022149
JPRN-UMIN000022149已完成未知

Surveillance in the digestive tract by capsule endoscopy after administration of immune checkpoint inhibitors - Surveillance in the digestive tract after immunotherapy

Keio University School of Medicine0 个研究点目标入组 30 人开始时间: 2016年7月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Pregnant female. 2. Patients with cardiac pacemakers or other medical electronic equipment. 3. Patients who have history of the ileus or stricture or fistula of the intestine. 4. Diagnosed or suspected Crohn's disease. 5. Patients with peritoneal dissemination. 6. Patients who are unsuccessful or difficult to perform esophagogastroduodenoscopy, colonoscopy, and small-bowel endoscopy. 7. Patients with dysphagia. 8. Allergy for mosapride, dimethicone, and low-volume polyethylene glycol solution (Moviprep). 9. Other conditions not suitable for this study.

研究者

相似试验